{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:14:28Z","timestamp":1792700068411,"version":"4.5.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold>To propose a theoretical formulation of engeletin-nanostructured lipid nanocarriers for improved delivery and increased bioavailability in treating Huntington\u2019s disease (HD).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>We conducted a literature review of the pathophysiology of HD and the limitations of currently available medications. We also reviewed the potential therapeutic benefits of engeletin, a flavanol glycoside, in treating HD through the Keap1\/nrf2 pathway. We then proposed a theoretical formulation of engeletin-nanostructured lipid nanocarriers for improved delivery across the blood-brain barrier (BBB) and increased bioavailability.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>HD is an autosomal dominant neurological illness caused by a repetition of the cytosine-adenine-guanine trinucleotide, producing a mutant protein called Huntingtin, which degenerates the brain\u2019s motor and cognitive functions. Excitotoxicity, mitochondrial dysfunction, oxidative stress, elevated concentration of ROS and RNS, neuroinflammation, and protein aggregation significantly impact HD development. Current therapeutic medications can postpone HD symptoms but have long-term adverse effects when used regularly. Herbal medications such as engeletin have drawn attention due to their minimal side effects. Engeletin has been shown to reduce mitochondrial dysfunction and suppress inflammation through the Keap1\/NRF2 pathway. However, its limited solubility and permeability hinder it from reaching the target site. A theoretical formulation of engeletin-nanostructured lipid nanocarriers may allow for free transit over the BBB due to offering a similar composition to the natural lipids present in the body a lipid solubility and increase bioavailability, potentially leading to a cure or prevention of HD.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold>The theoretical formulation of engeletin-nanostructured lipid nanocarriers has the potential to improve delivery and increase the bioavailability of engeletin in the treatment of HD, which may lead to a cure or prevention of this fatal illness.<\/jats:p>","DOI":"10.3389\/fphar.2023.1218625","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T06:31:26Z","timestamp":1688970686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington\u2019s disease via the nasal-brain route"],"prefix":"10.3389","volume":"14","author":[{"family":"Smriti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omji","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"Nasser Binjawhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma M.","family":"El-Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Algahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Altyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Abdel-Daim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.3390\/polym13234217","article-title":"Fabrication of Tizanidine loaded Patches using Flaxseed oil and Coriander oil as a penetration enhancer for transdermal delivery","volume":"13","author":"Akhlaq","year":"2021","journal-title":"Polymers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ng1095-115","article-title":"HEAT repeats in the Huntington's disease protein","volume":"11","author":"Andrade","year":"1995","journal-title":"Nat. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/biology9070161","article-title":"Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents","volume":"9","author":"Andr\u00e9","year":"2020","journal-title":"Biology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2019.00710","article-title":"International guidelines for the treatment of Huntington\u2019s disease","volume":"10","author":"Bachoud-L\u00e9vi","year":"2019","journal-title":"Front. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbrc.2020.03.091","article-title":"Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF-\u03baB-dependent signaling","volume":"526","author":"Bai","year":"2020","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/glia.10144","article-title":"Visualising microglial activation in vivo","volume":"40","author":"Banati","year":"2002","journal-title":"Glia"},{"key":"B8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00019052-199412000-00012","article-title":"Neurochemistry and toxin models in Huntington's disease","volume":"7","author":"Beal","year":"1994","journal-title":"Curr. Opin. neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: Promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2217\/nnm-2017-0022","article-title":"The effect of nanoparticle size on the ability to cross the blood\u2013brain barrier: An in vivo study","volume":"12","author":"Betzer","year":"2017","journal-title":"Nanomedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jmb.2005.10.053","article-title":"Oligoproline effects on polyglutamine conformation and aggregation","volume":"355","author":"Bhattacharyya","year":"2006","journal-title":"J. Mol. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s0149-7634(96)00027-9","article-title":"3-Nitropropionic acid animal model and Huntington's disease","volume":"21","author":"Borlongan","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J. Neurochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejpb.2022.02.004","article-title":"Is oral lipid-based delivery for drug targeting to the brain feasible?","volume":"172","author":"Brookes","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3\u2010nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J. Neurochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/13880209309082916","article-title":"Isolation, chemical identification and pharmacological evaluation of eucryphin, astilbin and engelitin obtained from the bark of Hymenaea martiana","volume":"31","author":"Carneiro","year":"1993","journal-title":"Int. J. Pharmacogn."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1161\/01.atv.20.7.1716","article-title":"Oxidation of LDL by myeloperoxidase and reactive nitrogen species: Reaction pathways and antioxidant protection","volume":"20","author":"Carr","year":"2000","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/glia.10145","article-title":"Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis","volume":"40","author":"Carson","year":"2002","journal-title":"Glia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1021\/jf021105j","article-title":"Phenolic composition of champagnes from Chardonnay and Pinot Noir vintages","volume":"51","author":"Chamkha","year":"2003","journal-title":"J. Agric. Food Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1alpha function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e115694","DOI":"10.1371\/journal.pone.0115694","article-title":"Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury","volume":"9","author":"Chen","year":"2014","journal-title":"PloS one"},{"key":"B26","first-page":"135","article-title":"Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington\u2019s disease","volume":"34","author":"Chen","year":"2011","journal-title":"Chang. Gung Med. J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1016\/s0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jep.2005.04.005","article-title":"Antioxidant activity in Australian native sarsaparilla (Smilax glyciphylla)","volume":"101","author":"Cox","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"B29","first-page":"431","article-title":"Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders","volume":"40","author":"Cramer","year":"1984","journal-title":"Adv. Neurol."},{"key":"B30","first-page":"219","article-title":"Behavioral changes in Huntington disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Cognitive Behav. Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/pharmaceutics12070599","article-title":"Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: Formulation variables and instrumental parameters","volume":"12","author":"Cunha","year":"2020","journal-title":"Pharmaceutics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.2147\/IJN.S305851","article-title":"Improving drug delivery for Alzheimer\u2019s disease through nose-to-brain delivery using nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ hydrogels","volume":"16","author":"Cunha","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"24126","DOI":"10.1021\/acsami.7b06510","article-title":"Poly (trehalose) nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington\u2019s Disease model mouse","volume":"9","author":"Debnath","year":"2017","journal-title":"ACS Appl. Mater. interfaces"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.3390\/nano12224073","article-title":"Improved activity of herbal medicines through Nanotechnology","volume":"12","author":"Dewi","year":"2022","journal-title":"Nanomaterials"},{"key":"B35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-m","article-title":"Excitotoxic injury of the neostriatum: A model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.2337\/diabetes.53.2007.s96","article-title":"Roles of mitochondria in health and disease","volume":"53","author":"Duchen","year":"2004","journal-title":"Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1002\/jps.24557","article-title":"Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer's disease: Optimization, biological efficacy, and potential toxicity","volume":"104","author":"Elnaggar","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0031-9422(83)83072-6","article-title":"Astilbin engeletin in grapes and wine","volume":"22","author":"Eugene","year":"1983","journal-title":"Phytochemistry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"114439","DOI":"10.1016\/j.biopha.2023.114439","article-title":"Engeletin mediates antiarrhythmic effects in mice with isoproterenol-induced cardiac remodeling","volume":"161","author":"Fang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12951-019-0546-3","article-title":"The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB","volume":"17","author":"Formicola","year":"2019","journal-title":"J. nanobiotechnology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"20211","DOI":"10.1074\/jbc.M401267200","article-title":"Inhibition of calpain cleavage of huntingtin reduces toxicity: Accumulation of calpain\/caspase fragments in the nucleus","volume":"279","author":"Gafni","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/glia.10155","article-title":"Microglia in human immunodeficiency virus\u2010associated neurodegeneration","volume":"40","author":"Garden","year":"2002","journal-title":"Glia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2015.06.054","article-title":"Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration","volume":"134","author":"Gartziandia","year":"2015","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"B45","first-page":"19","article-title":"Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis","volume":"85","author":"Go","year":"2012","journal-title":"Yale J. Biol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2021.05.003","article-title":"Methods for preparation of nanostructured lipid carriers","volume":"199","author":"Gomaa","year":"2022","journal-title":"Methods"},{"key":"B47","doi-asserted-by":"publisher","first-page":"110639","DOI":"10.1016\/j.mehy.2021.110639","article-title":"Demethyleneberberine: A possible treatment for Huntington\u2019s disease","volume":"153","author":"Gupta","year":"2021","journal-title":"Med. Hypotheses"},{"key":"B48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: A review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: Where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","article-title":"NF-\u03baB, the first quarter-century: Remarkable progress and outstanding questions","volume":"26","author":"Hayden","year":"2012","journal-title":"Genes & Dev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0896-6273(93)90209-a","article-title":"Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor","volume":"10","author":"Hollmann","year":"1993","journal-title":"Neuron"},{"key":"B53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4062\/biomolther.2022.088","article-title":"Involvement of IKK\/IkB\u03b1\/NF-kB p65 signaling into the regulative effect of engeletin on MUC5AC Mucin gene expression in human airway Epithelial cells","volume":"30","author":"Hossain","year":"2022","journal-title":"Biomol. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1021\/jf2002969","article-title":"Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties","volume":"59","author":"Huang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.tice.2023.102040","article-title":"Engeletin alleviates erastin-induced oxidative stress and protects against ferroptosis via Nrf2\/Keap1 pathway in bone marrow mesenchymal stem cells","volume":"82","author":"Huang","year":"2023","journal-title":"Tissue Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s10753-020-01250-9","article-title":"Engeletin attenuates A\u03b21\u201342-induced oxidative stress and neuroinflammation by keap1\/Nrf2 pathway","volume":"43","author":"Huang","year":"2020","journal-title":"Inflammation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2015.10.033","article-title":"Antidepressants for neuroprotection in Huntington's disease: A review","volume":"769","author":"Jamwal","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/foods10030636","article-title":"Fermented soy products: Beneficial potential in neurodegenerative diseases","volume":"10","author":"Jang","year":"2021","journal-title":"Foods"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/mds.25996","article-title":"Chorea associated with Huntington's disease: To treat or not to treat?","volume":"29","author":"Jankovic","year":"2014","journal-title":"Mov. Disord. Official J. Mov. Disord. Soc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10753-018-0773-z","article-title":"Protective and therapeutic effects of engeletin on LPS-induced acute lung injury","volume":"41","author":"Jiang","year":"2018","journal-title":"Inflammation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"11847","DOI":"10.3390\/ijms222111847","article-title":"Insights into the pathogenesis of neurodegenerative diseases: Focus on mitochondrial dysfunction and oxidative stress","volume":"22","author":"Jurcau","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats","volume":"1372","author":"Kalonia","year":"","journal-title":"Brain Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.pnpbp.2011.01.003","article-title":"Licofelone attenuates quinolinic acid induced huntington like symptoms: Possible behavioral, biochemical and cellular alterations","volume":"35","author":"Kalonia","year":"","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","article-title":"Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity","volume":"24","author":"Khoshnan","year":"2004","journal-title":"J. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jnr.20562","article-title":"Microglia in health and disease","volume":"81","author":"Kim","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-981-13-0944-1_18","article-title":"Management of HD: Insight into molecular mechanisms and potential neuroprotective drug strategies","volume":"2019","author":"Kumar","year":"2019","journal-title":"Pathology, Prev. Ther. Neurodegener. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1734-1140(10)70238-3","article-title":"Huntington\u2019s disease: Pathogenesis to animal models","volume":"62","author":"Kumar","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: Protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1146\/annurev-pharmtox-010814-124852","article-title":"Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier","volume":"55","author":"Lajoie","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease: Fourth in molecular medicine review Series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1523\/JNEUROSCI.15-07-05297.1995","article-title":"NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum","volume":"15","author":"Landwehrmeyer","year":"1995","journal-title":"J. Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mds.870010110","article-title":"Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography","volume":"1","author":"Leenders","year":"1986","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.2147\/JIR.S371809","article-title":"Engeletin alleviates the inflammation and apoptosis in Intervertebral Disc degeneration via inhibiting the NF-\u03baB and MAPK pathways","volume":"15","author":"Li","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/aps.2011.102","article-title":"Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms","volume":"32","author":"Li","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"B76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jep.2007.05.016","article-title":"A flavonoid glycoside isolated from Smilax China L. rhizome in vitro anticancer effects on human cancer cell lines","volume":"113","author":"Li","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"B77","doi-asserted-by":"crossref","first-page":"1934578X20986723","DOI":"10.1177\/1934578X20986723","article-title":"Inhibitory mechanism of engeletin against \u03b1-Glucosidase","volume":"16","author":"Li","year":"2021","journal-title":"Nat. Product. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e11028","DOI":"10.1590\/1414-431X2020e11028","article-title":"Engeletin protects against cerebral ischemia\/reperfusion injury by modulating the VEGF\/vasohibin and Ang-1\/Tie-2 pathways","volume":"54","author":"Liu","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"110221","DOI":"10.1016\/j.biopha.2020.110221","article-title":"Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress","volume":"128","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/s0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. neurological Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-e","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/hmg\/ddq460","article-title":"ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease","volume":"20","author":"Maher","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.molbrainres.2004.10.033","article-title":"3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells","volume":"133","author":"Mandavilli","year":"2005","journal-title":"Mol. Brain Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat. Genet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/309261a0","article-title":"Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones","volume":"309","author":"Mayer","year":"1984","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and Incidence of Huntington's disease: An Updated Systematic review and Meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Mov. Disord."},{"key":"B87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: Bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1871524919666181126124846","article-title":"Development and characterization of nasal delivery of selegiline hydrochloride loaded nanolipid carriers for the management of Parkinson\u2019s disease","volume":"19","author":"Mishra","year":"2019","journal-title":"Central Nerv. Syst. Agents Med. Chem. Former."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1471-4159.2006.03988.x","article-title":"Nitric oxide, cell bioenergetics and neurodegeneration","volume":"97","author":"Moncada","year":"2006","journal-title":"J. Neurochem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"B91","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nsmb1215","article-title":"A toxic monomeric conformer of the polyglutamine protein","volume":"14","author":"Nagai","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"73","DOI":"10.22270\/jddt.v7i3.1425","article-title":"Nanoparticles carrying natural product for drug delivery","volume":"7","author":"Ni","year":"2017","journal-title":"J. Drug Deliv. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuint.2016.12.018","article-title":"Brain mitochondrial calcium transport: Origins of the set-point concept and its application to physiology and pathology","volume":"109","author":"Nicholls","year":"2017","journal-title":"Neurochem. Int."},{"key":"B94","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ajps.2018.09.005","article-title":"Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances","volume":"14","author":"Niu","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejpb.2017.04.012","article-title":"Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery","volume":"117","author":"Noor","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B96","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/s0166-2236(96)01035-1","article-title":"NF-Kappa B: A crucial transcription factor for glial and neuronal cell function","volume":"20","author":"O'Neill","year":"1997","journal-title":"Trends Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood\u2013brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2015","journal-title":"Neuro-oncology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-022-00308-y","article-title":"The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders","volume":"11","author":"Olesen","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"B100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.toxlet.2003.12.017","article-title":"Mitochondrial regulation of apoptotic cell death","volume":"149","author":"Orrenius","year":"2004","journal-title":"Toxicol. Lett."},{"key":"B101","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10495-007-0756-2","article-title":"Mitochondria, oxidative stress and cell death","volume":"12","author":"Ott","year":"2007","journal-title":"Apoptosis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40199-019-00304-0","article-title":"Application of computational tools for the designing of Oleuropein loaded nanostructured lipid carrier for brain targeting through nasal route","volume":"27","author":"Palagati","year":"2019","journal-title":"DARU J. Pharm. Sci."},{"key":"B103","article-title":"Medicinal importance, pharmacological Activities and Analytical aspects of engeletin in the medicine: Therapeutic benefit through Scientific data analysis","volume-title":"Endocrine, metabolic & immune disorders drug targets","author":"Patel","year":"2022"},{"key":"B104","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10895-011-0985-1","article-title":"Binding of engeletin with bovine serum albumin: Insights from spectroscopic investigations","volume":"22","author":"Peng","year":"2012","journal-title":"J. Fluoresc."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","article-title":"Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases","volume":"91","author":"Perutz","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00415-021-10774-5","article-title":"Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: An analysis based on the global Burden of disease study 2019","volume":"269","author":"Raggi","year":"2022","journal-title":"J. Neurology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/IJN.S227805","article-title":"Novel drug delivery systems for loading of natural plant extracts and their biomedical applications","volume":"15","author":"Rahman","year":"2020","journal-title":"Int. J. nanomedicine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"113305","DOI":"10.1016\/j.biopha.2022.113305","article-title":"Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance","volume":"153","author":"Rahman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2009.09.009","article-title":"Aldose reductase: A novel therapeutic target for inflammatory pathologies","volume":"42","author":"Ramana","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","article-title":"The prevalence of Huntington's disease","volume":"46","author":"Rawlins","year":"2016","journal-title":"Neuroepidemiology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","article-title":"Genetics and neuropathology of Huntington's disease","volume":"98","author":"Reiner","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"B40","unstructured":"What is the international prevalence of Huntington disease (HD)? RevillaF. J. 2020"},{"key":"B112","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/archneur.64.6.813","article-title":"Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients","volume":"64","author":"Riba\u00ef","year":"2007","journal-title":"Archives neurology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis","volume":"16","author":"Rockabrand","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. rare Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, and clinical progression in Huntington's disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov. Disord."},{"key":"B116","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1074\/jbc.M208752200","article-title":"Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death","volume":"278","author":"Santos","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"B119","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12974-020-01782-9","article-title":"Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington\u2019s disease pathology","volume":"17","author":"Savage","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000072864","article-title":"Mechanisms of neuronal cell death in Huntington\u2019s disease","volume":"100","author":"Sawa","year":"2003","journal-title":"Cytogenet. genome Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tcb.2007.07.009","article-title":"ROS, mitochondria and the regulation of autophagy","volume":"17","author":"Scherz-Shouval","year":"2007","journal-title":"Trends Cell Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington\u2019s disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1471-4159.1977.tb10641.x","article-title":"Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: Correlations with Huntington's disease","volume":"28","author":"Schwarcz","year":"1977","journal-title":"J. Neurochem."},{"key":"B124","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-10711-0","volume-title":"Lipid nanoparticles: Production, characterization and stability","author":"Shah","year":"2015"},{"key":"B125","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.18632\/aging.202975","article-title":"Acetyl oxygen benzoate engeletin ester promotes KLF4 degradation leading to the attenuation of pulmonary fibrosis via inhibiting TGF\u03b21\u2013smad\/p38MAPK\u2013lnc865\/lnc556\u2013miR-29b-2-5p\u2013STAT3 signal pathway","volume":"13","author":"Shen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B126","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jconrel.2015.09.055","article-title":"Targeted endothelial nanomedicine for common acute pathological conditions","volume":"219","author":"Shuvaev","year":"2015","journal-title":"J. Control. Release"},{"key":"B127","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.mad.2005.09.012","article-title":"Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease?","volume":"127","author":"Squitieri","year":"2006","journal-title":"Mech. ageing Dev."},{"key":"B128","first-page":"625","article-title":"Phytomedicine: A potential alternative medicine in controlling neurological disorders","volume-title":"New look to phytomedicine","author":"Srivastava","year":"2019"},{"key":"B129","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1212\/wnl.24.9.813","article-title":"Biochemical abnormalities in Huntington's chorea brains","volume":"24","author":"Stahl","year":"1974","journal-title":"Neurology"},{"key":"B130","first-page":"112","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume-title":"Seminars in cell & developmental biology","author":"Subhramanyam","year":"2019"},{"key":"B131","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12017-008-8052-z","article-title":"Botanical phenolics and brain health","volume":"10","author":"Sun","year":"2008","journal-title":"Neuromolecular Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25:aid-art6>3.0.co;2-e","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1515\/revneuro.2010.21.4.299","article-title":"NF-kappaB signaling in neurite growth and neuronal survival","volume":"21","author":"Teng","year":"2010","journal-title":"Rev. Neurosci."},{"key":"B135","article-title":"Neurological disorders","volume":"87","author":"Thakur","year":"2016","journal-title":"Ment. Neurological, Subst. Use Disord."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/jn\/115.12.1673","article-title":"In vitro uptake of [3H]alpha-tocopherol from low density lipoprotein by cultured human fibroblasts","volume":"115","author":"Thellman","year":"1985","journal-title":"J. Nutr."},{"key":"B137","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jphs.2019.06.011","article-title":"Engeletin inhibits Lipopolysaccharide\/d-galactosamine-induced liver injury in mice through activating PPAR-\u03b3","volume":"140","author":"Tian","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ajcn\/40.4.747","article-title":"Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein","volume":"40","author":"Traber","year":"1984","journal-title":"Am. J. Clin. Nutr."},{"key":"B139","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","article-title":"HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation","volume":"137","author":"Tr\u00e4ger","year":"2014","journal-title":"Brain"},{"key":"B140","volume-title":"Astilbin and engeletin in grapes and wine. Phytochemistry","author":"Trousdale","year":"1983"},{"key":"B141","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/jfmk7020040","article-title":"Effects of exercise on skeletal muscle pathophysiology in Huntington\u2019s disease","volume":"7","author":"Trovato","year":"2022","journal-title":"J. Funct. Morphol. Kinesiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: Past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"B143","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1152\/jn.1998.79.2.555","article-title":"Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors","volume":"79","author":"Vicini","year":"1998","journal-title":"J. Neurophysiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11940-013-0219-8","article-title":"Treatment of huntington disease","volume":"15","author":"Videnovic","year":"2013","journal-title":"Curr. Treat. options neurology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2174\/1570159X18666201109090824","article-title":"Expanding the arsenal against Huntington's disease-Herbal drugs and their nanoformulations","volume":"19","author":"Vishwas","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1017\/S1740925X12000063","article-title":"Functions of microglia in the central nervous system\u2013beyond the immune response","volume":"7","author":"Wake","year":"2011","journal-title":"Neuron glia Biol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"11747","DOI":"10.1021\/acs.jafc.0c05102","article-title":"Aldose reductase inhibitor engeletin suppresses pelvic inflammatory disease by blocking the phospholipase C\/protein kinase C-dependent\/NF-\u03baB and MAPK cascades","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/JIR.S297166","article-title":"Engeletin protects against TNF-\u03b1-induced apoptosis and reactive oxygen species generation in chondrocytes and alleviates osteoarthritis in vivo","volume":"14","author":"Wang","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","article-title":"CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup","volume":"84","author":"Warby","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.2147\/DDDT.S338548","article-title":"Chemistry, biosynthesis, physicochemical and biological properties of rubiadin: A promising natural anthraquinone for new drug discovery and development","volume":"15","author":"Watroly","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington's disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurology"},{"key":"B153","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1021\/acs.jafc.6b02304","article-title":"Engeletin alleviates lipopolysaccharide-induced endometritis in mice by inhibiting TLR4-mediated NF-\u03baB activation","volume":"64","author":"Wu","year":"2016","journal-title":"J. Agric. food Chem."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e6535","DOI":"10.1371\/journal.pone.0006535","article-title":"Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice","volume":"4","author":"Yadav","year":"2009","journal-title":"PloS one"},{"key":"B155","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2174\/1573412914666180501114659","article-title":"Tissue distribution of engeletin in mice by UPLC-MS\/MS","volume":"15","author":"Ye","year":"2019","journal-title":"Curr. Pharm. Anal."},{"key":"B156","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jchromb.2017.06.018","article-title":"Determination and pharmacokinetics of engeletin in rat plasma by ultra-high performance liquid chromatography with tandem mass spectrometry","volume":"1060","author":"Ye","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"B157","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1385\/JMN:15:1:31","article-title":"Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease","volume":"15","author":"Yu","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1080\/13880209.2020.1834590","article-title":"Engeletin ameliorates pulmonary fibrosis through endoplasmic reticulum stress depending on lnc949-mediated TGF-\u03b21-Smad2\/3 and JNK signalling pathways","volume":"58","author":"Zhang","year":"2020","journal-title":"Pharm. Biol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1471-4159.2010.06763.x","article-title":"Excitotoxicity of TNFalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo","volume":"114","author":"Zhu","year":"2010","journal-title":"J. Neurochem."},{"key":"B160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/B978-0-12-814001-7.00007-X","article-title":"Brain drug delivery by adsorption-mediated transcytosis","volume-title":"Brain targeted drug delivery system","author":"Zhu","year":"2019"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1218625\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T21:58:01Z","timestamp":1729720681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1218625\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":160,"alternative-id":["10.3389\/fphar.2023.1218625"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1218625","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"article-number":"1218625"}}